Article

Lichtenberg, Frank (2017) The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia. Economic Record, 93 (302). 353 - 378. ISSN 0013-0249

Lichtenberg, Frank, Tatar, Mehtap and Çalışkan, Zafer (2017) The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination. Health Policy and Technology, 6 (2). 226 - 233. ISSN 2211-8837

Lichtenberg, Frank (2016) The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012. European Journal of Health Economics, 17 (7). 833 - 854. ISSN 1618-7598

Lichtenberg, Frank (2015) The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011. International Journal of Health Economics and Management, 15 (3). 339 - 359. ISSN 2199-9023

Lichtenberg, Frank (2015) The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010. Applied Health Economics and Health Policy, 13 (2). 207 - 222. ISSN 1175-5652

Hostenkamp, G and Lichtenberg, Frank (2015) The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence. Social Science and Medicine, 130. 162 - 171. ISSN 0277-9536

Lichtenberg, Frank (2015) The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland, 2003-2012. Nordic Journal of Health Economics. ISSN 1892-9710

Lichtenberg, Frank (2015) Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995–2010. International Journal of the Economics of Business, 22 (2). 277 - 299. ISSN 1357-1516

Lichtenberg, Frank (2014) Erratum to "Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000-2009" [Health Policy Technol. 3 (2014) 36-58]. Health Policy and Technology, 3 (4). 344 - 344. ISSN 2211-8837

Lichtenberg, Frank (2014) Has medical innovation reduced cancer mortality? CESifo Economic Studies, 60 (1). 135 - 177. ISSN 1610-241X

Lichtenberg, Frank (2014) Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000-2009. Health Policy and Technology, 3 (1). 36 - 58. ISSN 2211-8837

Lichtenberg, Frank (2014) The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997–2010. Journal of Human Capital, 8 (4). 432 - 480. ISSN 1932-8575

Lichtenberg, Frank and Pettersson, B (2014) The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: Evidence from longitudinal, disease-level data. Economics of Innovation and New Technology, 23 (3). 239 - 273. ISSN 1043-8599

Lichtenberg, Frank (2014) The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009. Economics and Human Biology, 13 (1). 107 - 127. ISSN 1570-677X

Lichtenberg, Frank, Tatar, Mehtap and Çalışkan, Zafer (2014) The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999-2010. Health Policy, 117 (3). 361 - 373. ISSN 0168-8510

Lichtenberg, Frank (2013) The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000-2007. Social Science and Medicine, 77 (1). 50 - 59. ISSN 0277-9536

Lichtenberg, Frank (2011) Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being. Health Affairs, 30 (8). 1539 - 1544. ISSN 0278-2715

Jönsson, B, Lichtenberg, Frank and Wilking, N (2007) Reply to 'Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)' by Michel P Coleman. Annals of Oncology, 18 (9). 1585 - 1587. ISSN 0923-7534

Lichtenberg, Frank (2006) The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: State-level evidence from 1997 to 2003. PharmacoEconomics, 24 (S3). 5 - 25. ISSN 1170-7690

Lichtenberg, Frank (2006) The impact of increased utilization of HIV drugs on longevity and medical expenditure: An assessment based on aggregate US time-series data. Expert Review of Pharmacoeconomics and Outcomes Research, 6 (4). 425 - 436. ISSN 1473-7167

Lichtenberg, Frank (2006) Did CMS' functional equivalence decision result in equitable payments? Journal of Pharmaceutical Finance, Economics and Policy, 15 (1). 7 - 20. ISSN 1538-5698

Lichtenberg, Frank (2005) Pharmaceutical innovation and the burden of disease in developing and developed countries. Journal of Medicine and Philosophy, 30 (6). 663 - 690. ISSN 0360-5310

Lichtenberg, Frank (2004) Sources of U.S. longevity increase, 1960-2001. Quarterly Review of Economics and Finance, 44 (3). 369 - 389. ISSN 1062-9769

Lichtenberg, Frank (2003) The effect of new drug approvals on HIV mortality in the US, 1987-1998. Economics and Human Biology, 1 (2). 259 - 266. ISSN 1570-677X

Lichtenberg, Frank (2001) Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS. Health Affairs, 20 (5). 241 - 251. ISSN 0278-2715

Lichtenberg, Frank (2001) Probing the link between gross profitability and R&D spending. Health Affairs, 20 (5). 221 - 222. ISSN 0278-2715

Van Pottelsberghe De La Potterie, B and Lichtenberg, Frank (2001) Does foreign direct investment transfer technology across borders? Review of Economics and Statistics, 83 (3). 490 - 497. ISSN 1530-9142

Lichtenberg, Frank and Pushner, GM (1994) Ownership structure and corporate performance in Japan. Japan and The World Economy, 6 (3). 239 - 261. ISSN 0922-1425

Monograph

Lichtenberg, Frank (2016) The Benefits of Pharmaceutical Innovation: Health, Longevity, and Savings. Project Report. Montreal Economic Institute, Canada.